IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Tybourne Capital Management HK LTD

Q1 2025 Holdings

Filed 2025-05-15 | 5 holdings | $23.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Acelyrin Inc (Slrn US)COM00445A100$7.2M2,906,62930.5%
Taysha Gene Therapies Inc (Tsha US)(TSHA)COM SHS877619106$5.1M3,700,00021.8%
Bicycle Therapeutics Ltd-ADR (Bcyc US)(BCYC)SPONSORED ADS088786108$4.9M576,34320.8%
Forte Biosciences Inc (Fbrx US)(FBRX)COM NEW34962G208$4.8M619,98120.4%
Zentalis Pharmaceuticals Inc (Zntl US)(ZNTL)COM98943L107$1.5M961,4866.5%